Professor Kim-Beomjun – Lee-Donggi team, developed tech for scar removal
- 자연과학대학
- Hit3398
- 2016-09-12
"Hypertrophic scar" and "keloid scar" treatment resulting from surgery or trauma has been developed by Kim-Beomjun (Chung-Ang University Hospital Professor) Lee-Donggi (Sungkyunkwan University chemistry professor team). Recently they developed technologies of intractable hypertrophic scarring and keloid scar treatment. The thesis (Development of cell-penetrating asymmetric interfering RNA targeting connective tissue growth factor (CTGF)) was published in the journal 'Exploratory dermatology journals (Journal of Investigative Dermatology, JID)' which is prestigious in international dermatology areas. It was published in the current issue.
Professor Kim, Lee and his team have developed RNAi technology, which injects chemically synthesized RNA (Ribo Nucleic Acid, Ribonucleic acid) cells within scarring associated genes He explained that it could be used as a fundamental treatment of keloid scars and intractable hypertrophic scars.
So far there is no truly successful treatment that received Food and Drug Administration (FDA) approval. The study was conducted jointly by Olix, Sungkyunkwan University and Hugel supported by the Small and Medium Business Administration as global hidden champions challenges.